Perspective · 15 Aug 2025
Research articlePublished 30 Apr 2020
Role of Rituximab in the Treatment of Different Hematological Disorders
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rituximab (anti-CD20 antibody) has been approved as a treatment for B-cell associated hematological disorders. CD20 expression and its complement regulatory proteins and membrane binding structures play a crucial role in rituximab efficacy. Complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity are the major mechanisms by which rituximab eliminates B cells. The efficacy of anti-CD20 varies in different diseases. Rituximab was approved as a successful treatment in diseases such as non-Hodgkin lymphomas, particularly diffuse large B-cell lymphoma and follicular lymphoma. In addition, rituximab has recently shown promising results with several autoimmune diseases; it was approved for rheumatoid arthritis as well as being used for other diseases such as systemic lupus erythematosus. Likewise, rituximab was successfully used for incompatible ABO organ transplantation instead of the invasive splenectomy procedure. This review will discuss the use of rituximab for different hematological diseases.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · Mar 2011
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Short communication · 31 Aug 2020
SLE- A HEMATOLOGICAL DISORDER AND KOZHIKODE CRITERIA FOR SLE
Article · 2015
Metabolic Disorders in Hematologic Malignancies- A Review
Case report · 2022
Rituximab induced interstitial lung disease Diagnosis, treatment outcome, and Risk’s factor, a place for Transbronchial pulmonary Cryobiopsy
More from this journal
The newest in International Journal of Medical Research & Health Sciences.
Article · 25 Feb 2026
The Utility of STRIATIN as A Novel Diagnostic Marker in Cirrhosis
Article · 19 Feb 2026
Sialadenoma Papilliferum: "A Rare Benign Salivary Gland Tumor"
Article · 10 Dec 2025
Link between Nephrolithiasis and Sialolithiasis-A Comprehensive Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Medical Research & Health Sciences
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Walaa F. Alsanie”
